Dr. Reddy's Laboratories Ltd


in
Dr. Reddy's Laboratories Ltd. has filed for a declaratory verdict on its patent on the cardio drug, Nexium, in the New Jersey district court in the US. The company intends to trigger exclusivity on the drug before 2014. DRL and Astra Zeneca are engaged in a legal dispute on Nexium patent infringements.